济民健康
(603222)
| 流通市值：73.09亿 | | | 总市值：73.09亿 |
| 流通股本：5.25亿 | | | 总股本：5.25亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 349,727,496.51 | 534,117,213.47 | 313,233,288.5 | 190,594,807.75 |
| 交易性金融资产 | - | - | - | 100,000,000 |
| 应收票据及应收账款 | 143,063,462.77 | 139,083,012.29 | 126,974,794.39 | 192,599,979.68 |
| 应收账款 | 143,063,462.77 | 139,083,012.29 | 126,974,794.39 | 192,599,979.68 |
| 应收款项融资 | 1,613,045.97 | 1,718,934.67 | 4,190,977.02 | 11,333,294.4 |
| 预付款项 | 6,029,711.75 | 6,744,378.1 | 6,235,164.58 | 10,404,647.45 |
| 其他应收款合计 | 53,512,844.13 | 50,968,809.97 | 81,097,954.72 | 8,444,661.18 |
| 存货 | 149,389,802.25 | 173,441,297.13 | 174,108,449.24 | 157,422,417.39 |
| 一年内到期的非流动资产 | - | - | - | 44,800,000 |
| 其他流动资产 | 3,984,529.64 | 6,800,186.75 | 9,409,841.46 | 2,178,523.55 |
| 流动资产合计 | 707,320,893.02 | 912,873,832.38 | 715,250,469.91 | 717,778,331.4 |
| 非流动资产: | | | | |
| 长期股权投资 | 150,157,987.42 | 160,718.27 | 164,020.11 | 165,126.01 |
| 其他非流动金融资产 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 |
| 固定资产 | 1,257,142,416.62 | 1,260,137,512.94 | 1,278,225,227.88 | 1,132,893,018.23 |
| 在建工程 | 187,610.62 | 13,560,029.84 | 10,239,633.95 | 215,755,338.48 |
| 使用权资产 | 68,997,074.57 | 71,355,368.21 | 74,493,615.68 | 77,283,938.17 |
| 无形资产 | 198,811,411.94 | 200,809,557.95 | 202,931,251.39 | 204,749,784.22 |
| 商誉 | 35,142,275.12 | 35,142,275.12 | 35,142,275.12 | 35,142,275.12 |
| 长期待摊费用 | 47,577,489.96 | 48,992,136.18 | 50,239,485.85 | 2,231,861.29 |
| 递延所得税资产 | 46,186,165.71 | 40,432,631.33 | 37,390,127.07 | 27,450,724.16 |
| 其他非流动资产 | 10,378,742.11 | 4,367,299.5 | 4,311,186.76 | 8,143,679.79 |
| 非流动资产合计 | 1,820,581,174.07 | 1,680,957,529.34 | 1,699,136,823.81 | 1,709,815,745.47 |
| 资产总计 | 2,527,902,067.09 | 2,593,831,361.72 | 2,414,387,293.72 | 2,427,594,076.87 |
| 流动负债: | | | | |
| 短期借款 | 409,159,914.36 | 397,226,802.01 | 180,155,976.27 | 183,281,973.15 |
| 应付票据及应付账款 | 149,689,773.62 | 151,607,176.12 | 168,300,418.54 | 155,481,942.04 |
| 其中：应付票据 | 22,030,000 | 24,459,580 | 28,634,580 | 35,738,000 |
| 应付账款 | 127,659,773.62 | 127,147,596.12 | 139,665,838.54 | 119,743,942.04 |
| 预收款项 | 5,351.7 | 8,562.72 | 11,773.74 | 2,140.68 |
| 合同负债 | 50,468,365.13 | 70,852,357.13 | 59,794,216.88 | 45,675,636.34 |
| 应付职工薪酬 | 16,321,119.26 | 16,045,212.97 | 23,176,624.7 | 19,031,530.98 |
| 应交税费 | 5,694,763.63 | 2,483,799.07 | 8,204,101.36 | 10,909,501.62 |
| 其他应付款合计 | 18,441,101.85 | 19,299,975.03 | 19,812,133.55 | 16,943,497.5 |
| 一年内到期的非流动负债 | 13,342,255.8 | 21,676,817.42 | 23,053,296.82 | 18,880,291.54 |
| 其他流动负债 | 3,770,563.02 | 4,716,358.66 | 4,069,314.51 | 3,157,373.16 |
| 流动负债合计 | 666,893,208.37 | 683,917,061.13 | 486,577,856.37 | 453,363,887.01 |
| 非流动负债: | | | | |
| 长期借款 | 252,879,460.1 | 259,941,013.38 | 259,206,408.97 | 240,083,643.2 |
| 租赁负债 | 61,065,555.96 | 64,161,914.45 | 63,414,934.1 | 62,235,128.84 |
| 长期应付款 | 877,891.91 | 914,281.89 | 958,931.32 | 1,133,725.36 |
| 预计负债 | 26,111,569.55 | 28,317,131.68 | 28,317,131.68 | - |
| 递延收益 | 5,829,442.77 | 6,186,983.22 | 7,745,690.16 | 9,413,313.96 |
| 递延所得税负债 | - | - | - | 183,708.55 |
| 非流动负债合计 | 346,763,920.29 | 359,521,324.62 | 359,643,096.23 | 313,049,519.91 |
| 负债合计 | 1,013,657,128.66 | 1,043,438,385.75 | 846,220,952.6 | 766,413,406.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 525,090,615 | 525,090,615 | 525,090,615 | 537,237,415 |
| 资本公积 | 599,518,440.93 | 599,518,440.93 | 599,518,440.93 | 679,562,049.43 |
| 减:库存股 | 12,090,917.77 | 8,552,467.5 | - | 91,619,396.01 |
| 其他综合收益 | 7,259,247.71 | 1,847,542.57 | -629,236.32 | 2,222,810.86 |
| 盈余公积 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 |
| 未分配利润 | 266,779,939.27 | 305,839,338.67 | 319,475,792.1 | 407,602,557.57 |
| 归属于母公司股东权益合计 | 1,423,926,583.03 | 1,461,112,727.56 | 1,480,824,869.6 | 1,572,374,694.74 |
| 少数股东权益 | 90,318,355.4 | 89,280,248.41 | 87,341,471.52 | 88,805,975.21 |
| 股东权益合计 | 1,514,244,938.43 | 1,550,392,975.97 | 1,568,166,341.12 | 1,661,180,669.95 |
| 负债和股东权益合计 | 2,527,902,067.09 | 2,593,831,361.72 | 2,414,387,293.72 | 2,427,594,076.87 |
| 公告日期 | 2025-08-21 | 2025-04-29 | 2025-04-29 | 2024-10-30 |
| 审计意见(境内) | | | 带强调事项段的无保留意见 | |